Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection
โ Scribed by Hubert E. Blum; T. Jake Liang; Eithan Galun; Jack R. Wands
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 809 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
Chronic hepatitis B virus infection is a major medical problem worldwide. Apart from HBsAg carriers, hepatitis B virus has also been identified in some HBsAg-individuals with or without antibodies to viral antigens. The molecular mechanisms underlying hepatitis B virus persistence in HBsAg-individuals are unresolved, however. To identify a possible genetic basis for viral persistence, we cloned the viral genome from the liver of a patient serologically immune to hepatitis B virus infection. DNA sequence analysis of the complete viral genome identified numerous mutations in all viral genes. Analysis of the biological effects of these mutations revealed three major findings: a low level of HBsAg synthesis, absence of HBeAg production and a defect terminating viral replication. These data suggest that mutations accumulating during the natural course of hepatitis B virus infection may be a mechanism underlying viral persistence in HBsAgindividuals, presumably through escape from immune surveillance. (HEPATOLOGY 1991; 14:56-62.) Chronic HBV infection and its sequelae are major medical problems throughout the world. Apart from HBsAg-t individuals, HBV DNA species have also been detected in serum or liver from some HBsAg -patients and experimental animals with or without antibodies to viral antigens (1-11). The molecular structure and biology of these viral DNA species have not been characterized in detail, however. Recently, mutations have been identified in the surface (12-14) and precorelcore regions (15-24) of the viral genome, respectively. In clinical terms, some of these mutations were shown to result in inefficiency of HBV vaccination (13)
๐ SIMILAR VOLUMES
To define the duration of viremia in the course of acute hepatitis B, we semiquantitatively determined the levels of hepatitis B virus (HBV) DNA in the sera, using polymerase chain reaction (PCR) coupled with Southern blotting, of non-immunocompromised patients with self-limited acute hepatitis B. I
The presence of hepatitis B virus DNA in serum was determined in 57 unselected patients during the course from acute to chronic hepatitis B infection. Forty-six (81%) patients were hepatitis B virus DNA-positive in the first available serum sample. Generally, hepatitis B virus DNA was cleared before